Viewing Study NCT01231594


Ignite Creation Date: 2025-12-25 @ 1:38 AM
Ignite Modification Date: 2026-01-08 @ 12:48 AM
Study NCT ID: NCT01231594
Status: COMPLETED
Last Update Posted: 2019-03-22
First Post: 2010-10-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive Tumors
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module